Top Clinical Trials companies in United States by Free Cash Flow Yield
United States
# |
Name |
Free Cash Flow Yield |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
10.49% |
Jan. 14, 2025 | USD 36.67 | -1.26% |
|
United States |
|
| 2 |
8.24% |
Jan. 14, 2025 | USD 37.82 | 0.66% |
|
United States |
|
| 3 |
6.16% |
Jan. 14, 2025 | USD 178.08 | -6.34% |
|
United States |
|
| 4 |
5.61% |
Jan. 14, 2025 | USD 25.46 | -2.64% |
|
United States |
|
| 5 |
5.21% |
Jan. 14, 2025 | USD 330.91 | -5.99% |
|
United States |
|
| 6 |
4.16% |
Jan. 14, 2025 | USD 35.65 | 0.99% |
|
United States |
|
| 7 |
3.61% |
Jan. 14, 2025 | USD 16.69 | -2.46% |
|
United States |
|
| 8 |
3.12% |
Jan. 14, 2025 | USD 139.51 | -2.46% |
|
United States |
|
| 9 |
2.63% |
Jan. 14, 2025 | USD 51.66 | 1.18% |
|
United States |
|
| 10 |
1.95% |
Jan. 14, 2025 | USD 19.11 | -5.68% |
|
United States |
|
| 11 |
1.42% |
Jan. 14, 2025 | USD 142.64 | -5.10% |
|
United States |
|
| 12 |
0.12% |
Jan. 14, 2025 | USD 71.93 | -0.61% |
|
United States |
|
| 13 |
0.10% |
Jan. 14, 2025 | USD 64.65 | -4.02% |
|
United States |
|
| 14 |
0.05% |
Jan. 14, 2025 | USD 240.51 | -6.88% |
|
United States |
|
| 15 |
-0.35% |
Jan. 14, 2025 | USD 43.32 | -1.54% |
|
United States |
|
| 16 |
-0.47% |
Jan. 14, 2025 | USD 126.89 | -0.24% |
|
United States |
|
| 17 |
-0.61% |
Jan. 14, 2025 | USD 29.74 | 7.48% |
|
United States |
|
| 18 |
-0.92% |
Jan. 14, 2025 | USD 16.65 | -8.42% |
|
United States |
|
| 19 |
-1.10% |
Jan. 14, 2025 | USD 411.66 | -0.41% |
|
United States |
|
| 20 |
-1.22% |
Jan. 14, 2025 | USD 13.78 | 9.11% |
|
United States |
|
| 21 |
-1.42% |
Jan. 14, 2025 | USD 45.35 | 0.64% |
|
United States |
|
| 22 |
-1.85% |
Jan. 7, 2025 | USD 9.50 | NA |
|
United States |
|
| 23 |
-1.96% |
Jan. 14, 2025 | USD 33.93 | -12.73% |
|
United States |
|
| 24 |
-2.81% |
Jan. 14, 2025 | USD 42.54 | -1.21% |
|
United States |
|
| 25 |
-2.98% |
Jan. 14, 2025 | USD 72.39 | 0.74% |
|
United States |
|
| 26 |
-3.23% |
Jan. 14, 2025 | USD 84.60 | -5.23% |
|
United States |
|
| 27 |
-3.47% |
Jan. 14, 2025 | USD 10.47 | -0.76% |
|
United States |
|
| 28 |
-3.59% |
Jan. 14, 2025 | USD 31.64 | -2.65% |
|
United States |
|
| 29 |
-3.84% |
Jan. 14, 2025 | USD 102.56 | -0.77% |
|
United States |
|
| 30 |
-3.91% |
Jan. 14, 2025 | USD 24.98 | -2.76% |
|
United States |
|
| 31 |
-3.99% |
Jan. 14, 2025 | USD 4.06 | -2.64% |
|
United States |
|
| 32 |
-4.14% |
Jan. 14, 2025 | USD 118.83 | 0.34% |
|
United States |
|
| 33 |
-4.23% |
Jan. 14, 2025 | USD 27.52 | 8.65% |
|
United States |
|
| 34 |
-4.89% |
Jan. 14, 2025 | USD 57.83 | -1.55% |
|
United States |
|
| 35 |
-5.53% |
Jan. 14, 2025 | USD 34.59 | -0.52% |
|
United States |
|
| 36 |
-5.84% |
Jan. 14, 2025 | USD 27.05 | -4.79% |
|
United States |
|
| 37 |
-5.93% |
Jan. 14, 2025 | USD 37.46 | -1.68% |
|
United States |
|
| 38 |
-6.16% |
Jan. 14, 2025 | USD 35.62 | -8.62% |
|
United States |
|
| 39 |
-6.25% |
Jan. 14, 2025 | USD 12.69 | -0.78% |
|
United States |
|
| 40 |
-6.69% |
Jan. 14, 2025 | USD 12.59 | -1.02% |
|
United States |
|
| 41 |
-6.75% |
Jan. 14, 2025 | USD 5.10 | -1.92% |
|
United States |
|
| 42 |
-6.86% |
Jan. 14, 2025 | USD 20.46 | -7.29% |
|
United States |
|
| 43 |
-6.90% |
Jan. 14, 2025 | USD 2.50 | 0.81% |
|
United States |
|
| 44 |
-7.01% |
Jan. 14, 2025 | USD 3.20 | -2.44% |
|
United States |
|
| 45 |
-7.13% |
Jan. 14, 2025 | USD 1.58 | -4.24% |
|
United States |
|
| 46 |
-7.19% |
Jan. 14, 2025 | USD 25.38 | 0.87% |
|
United States |
|
| 47 |
-7.32% |
Jan. 14, 2025 | USD 6.37 | 0.63% |
|
United States |
|
| 48 |
-7.33% |
Jan. 14, 2025 | USD 274.12 | -9.74% |
|
United States |
|
| 49 |
-7.49% |
Jan. 14, 2025 | USD 39.83 | -6.44% |
|
United States |
|
| 50 |
-7.63% |
Jan. 14, 2025 | USD 45.23 | -3.17% |
|
United States |
Frequently Asked Questions
-
Which Clinical Trials company in United States has the highest Free Cash Flow Yield ?
The Clinical Trials company in United States with the highest Free Cash Flow Yield is Protagonist Therapeutics, Inc. (NasdaqGM: PTGX) at 10.49%.
-
Which Clinical Trials company in United States has the lowest Free Cash Flow Yield ?
The Clinical Trials company in United States with the lowest Free Cash Flow Yield is TransCode Therapeutics, Inc. (NasdaqCM: RNAZ) at -677.04%.
-
What are the top 10 Clinical Trials companies in United States by Free Cash Flow Yield ?
The top 10 Clinical Trials companies in United States by Free Cash Flow Yield are Protagonist Therapeutics, Inc., Supernus Pharmaceuticals, Inc., Charles River Laboratories International, Inc., Castle Biosciences, Inc., Medpace Holdings, Inc., Exelixis, Inc., Rigel Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., Corcept Therapeutics Incorporated and Xencor, Inc..
-
What are the bottom 10 Clinical Trials companies in United States by Free Cash Flow Yield ?
The bottom 10 Clinical Trials companies in United States by Free Cash Flow Yield are TransCode Therapeutics, Inc., Vaccinex, Inc., Theriva Biologics, Inc., Allarity Therapeutics, Inc., Aptevo Therapeutics Inc., HOOKIPA Pharma Inc., RAPT Therapeutics, Inc., Dominari Holdings Inc., Palisade Bio, Inc. and Agenus Inc..